Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19)

Shuai Wang, Bo Kang, Jinlu Ma, Xianjun Zeng, Mingming Xiao, Jia Guo, Mengjiao Cai, Jingyi Yang, Yaodong Li, Xiangfei Meng, Bo Xu
doi: https://doi.org/10.1101/2020.02.14.20023028
Shuai Wang
1Department of Molecular Radiation Oncology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin Clinical Research Center for Cancer, Tianjin Medical University Cancer Hospital and Institute, Tianjin 300060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Bo Kang
2College of Intelligence and Computing, Tianjin University, Tianjin 300350, China
3National Supercomputer Center in Tianjin, Tianjin 300457, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinlu Ma
4Department of Radiation Oncology, First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xianjun Zeng
5Department of Radiology, Nanchang University First Hospital, Nanchang, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mingming Xiao
1Department of Molecular Radiation Oncology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin Clinical Research Center for Cancer, Tianjin Medical University Cancer Hospital and Institute, Tianjin 300060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jia Guo
3National Supercomputer Center in Tianjin, Tianjin 300457, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Mengjiao Cai
4Department of Radiation Oncology, First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jingyi Yang
4Department of Radiation Oncology, First Affiliated Hospital, Xi’an Jiaotong University, Xi’an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yaodong Li
6Department of Radiology, No.8 Hospital, Xi’an Medical College, Xi’an, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiangfei Meng
2College of Intelligence and Computing, Tianjin University, Tianjin 300350, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xubo@tmu.edu.cn mengxf@nscc-tj.cn
Bo Xu
1Department of Molecular Radiation Oncology, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Key Laboratory of Breast Cancer Prevention and Therapy, Ministry of Education, Tianjin Clinical Research Center for Cancer, Tianjin Medical University Cancer Hospital and Institute, Tianjin 300060, China
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: xubo@tmu.edu.cn mengxf@nscc-tj.cn
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Background To control the spread of Corona Virus Disease (COVID-19), screening large numbers of suspected cases for appropriate quarantine and treatment measures is a priority. Pathogenic laboratory testing is the diagnostic gold standard but it is time consuming with significant false positive results. Fast and accurate diagnostic methods are urgently needed to combat the disease. Based on COVID-19 radiographical changes in CT images, we hypothesized that deep learning methods might be able to extract COVID-19’s graphical features and provide a clinical diagnosis ahead of the pathogenic test, thus saving critical time for disease control.

Methods We collected 453 CT images of pathogen-confirmed COVID-19 cases along with previously diagnosed with typical viral pneumonia. We modified the Inception migration-learning model to establish the algorithm, followed by internal and external validation.

Findings The internal validation achieved a total accuracy of 82·9% with specificity of 80·5% and sensitivity of 84%. The external testing dataset showed a total accuracy of 73·1% with specificity of 67% and sensitivity of 74%.

Interpretation These results demonstrate the proof-of-principle for using artificial intelligence to extract radiological features for timely and accurate COVID-19 diagnosis.

Funding No funding is involved in the execution of the project.

Evidence before this study Fast and accurate screening large numbers of cases with viral pneumonia symptoms for appropriate quarantine and treatment measures is a priority to control the spread of Corona Virus Disease (COVID-19). Pathogenic laboratory testing is the diagnostic gold standard but it is time-consuming with significant false positive results. Computed tomography (CT) is also a major diagnostic tool for COVID-19. Although typical CT images may help early screening of suspected cases, the images of various viral pneumonias are similar and they overlap with other infectious and inflammatory lung diseases. Artificial intelligent technologies such as deep learning might be able to extract COVID-19’s graphical features and provide a clinical diagnosis. However, there is no published work exploring this possibility.

Added value of this study Our study represents the first study to apply artificial intelligence technologies to CT images for effectively screening for COVID-19. We employed a modified Inception migration-learning model to establish the algorithm. The internal validation achieved a total accuracy of 82·9% with specificity of 80·5% and sensitivity of 84%. The external testing dataset showed a total accuracy of 73·1% with specificity of 67% and sensitivity of 74%. The time for each case is about 2 seconds and can be done remotely via a shared public platform.

Implications of all the available evidence To control the outbreak of COVID-19, it is crucial to develop fast, accurate, safe and non-invasive methods for early diagnosis. We present a proof-of-principle of such as method. We believe that with more data included for further optimization and testing, the accuracy, specificity and sensitivity can be improved. Such a platform can be used to assist clinical diagnosis.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding

Author Declarations

All relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.

Yes

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Data Availability

All data referred to in the manuscript is available.

https://ai.nscc-tj.cn/thai/deploy/public/pneumonia_ct

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted February 18, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19)
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19)
Shuai Wang, Bo Kang, Jinlu Ma, Xianjun Zeng, Mingming Xiao, Jia Guo, Mengjiao Cai, Jingyi Yang, Yaodong Li, Xiangfei Meng, Bo Xu
medRxiv 2020.02.14.20023028; doi: https://doi.org/10.1101/2020.02.14.20023028
Digg logo Reddit logo Twitter logo Facebook logo Google logo LinkedIn logo Mendeley logo
Citation Tools
A deep learning algorithm using CT images to screen for Corona Virus Disease (COVID-19)
Shuai Wang, Bo Kang, Jinlu Ma, Xianjun Zeng, Mingming Xiao, Jia Guo, Mengjiao Cai, Jingyi Yang, Yaodong Li, Xiangfei Meng, Bo Xu
medRxiv 2020.02.14.20023028; doi: https://doi.org/10.1101/2020.02.14.20023028

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (175)
  • Allergy and Immunology (421)
  • Anesthesia (97)
  • Cardiovascular Medicine (901)
  • Dentistry and Oral Medicine (170)
  • Dermatology (102)
  • Emergency Medicine (257)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (407)
  • Epidemiology (8792)
  • Forensic Medicine (4)
  • Gastroenterology (405)
  • Genetic and Genomic Medicine (1864)
  • Geriatric Medicine (179)
  • Health Economics (388)
  • Health Informatics (1292)
  • Health Policy (644)
  • Health Systems and Quality Improvement (492)
  • Hematology (207)
  • HIV/AIDS (395)
  • Infectious Diseases (except HIV/AIDS) (10570)
  • Intensive Care and Critical Care Medicine (564)
  • Medical Education (193)
  • Medical Ethics (52)
  • Nephrology (218)
  • Neurology (1758)
  • Nursing (103)
  • Nutrition (267)
  • Obstetrics and Gynecology (343)
  • Occupational and Environmental Health (461)
  • Oncology (965)
  • Ophthalmology (283)
  • Orthopedics (107)
  • Otolaryngology (177)
  • Pain Medicine (118)
  • Palliative Medicine (43)
  • Pathology (264)
  • Pediatrics (557)
  • Pharmacology and Therapeutics (266)
  • Primary Care Research (220)
  • Psychiatry and Clinical Psychology (1846)
  • Public and Global Health (3989)
  • Radiology and Imaging (655)
  • Rehabilitation Medicine and Physical Therapy (344)
  • Respiratory Medicine (536)
  • Rheumatology (215)
  • Sexual and Reproductive Health (178)
  • Sports Medicine (166)
  • Surgery (197)
  • Toxicology (37)
  • Transplantation (107)
  • Urology (80)